Manish Oswal Profile
Key Indicators
- Authorised Capital ₹ 0.15 M
- Paid Up Capital ₹ 0.15 M
- Company Age 4 Year, 13 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 8.81 Cr
- Revenue Growth %
- Profit Growth 265.32%
- Ebitda 88.46%
- Net Worth 214.08%
- Total Assets 2.46%
About Manish Oswal
Manish Oswal Private Limited (MOPL) is a Private Limited Indian Non-Government Company incorporated in India on 09 February 2021 (Four years 13 days old ). Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.15 M and a paid-up capital of Rs 0.15 M.
The company currently has active open charges totaling ₹8.81 Cr.
Manish Oswal, Sarika Oswal, and Meet Oswal serve as directors at the Company.
Company Details
- Location
Pune, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85300PN2021PTC198441
- Company No.
198441
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Feb 2021
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Manish Oswal?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manish Oswal  | Director | 09-Feb-2021 | Current |
| Sarika Oswal | Director | 09-Feb-2021 | Current |
| Meet Oswal | Director | 13-Aug-2021 | Current |
Financial Performance of Manish Oswal.
Manish Oswal Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 265.32% increase in profit. The company's net worth Soared by an impressive increase of 214.08%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Manish Oswal?
Unlock access to Manish Oswal's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Medipoint Hospitals Private LimitedManish Oswal is a mutual person
Endovision Pharma Private LimitedManish Oswal is a mutual person
Charges (Loans)
₹88.11 M
₹0
Charges Breakdown by Lending Institutions
- Others : 8.81 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Sep 2022 | Others | ₹8.81 Cr | Open |
How Many Employees Work at Manish Oswal?
Manish Oswal has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Manish Oswal, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Manish Oswal's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.